Funding
Series B · Robotics

Multiply Labs raises $75m Series B for robotic medicine manufacturing

Multiply Labs builds robotics for manufacturing personalized medicines, helping drug makers produce individualized treatments with less manual work.

Updated Oct 16, 2026By RoundOS Funding desk

The financing supports scaling robotic manufacturing for individualized medicines. Multiply Labs automates repeatable production steps while accommodating treatments made for specific patients.

Funding history

Series B · This round$75M

Sources

  1. VC funding deals: Vinci, Capitolis, Multiply Labs - InfotechLeadinfotechlead.com · Oct 1, 2026
  2. startupdb.com

Similar rounds

All Robotics rounds →
Warp Sciences

Warp Sciences combines chemistry, AI and robotics to help drug discovery teams make and test molecules in the United States.

$215MSeries A · Oct 22, 2026
NAiSE

NAiSE coordinates robots, forklifts and material movement through software for warehouses and factories.

UndisclosedStrategic stake investment · Oct 22, 2026
Maxinsights

Maxinsights supplies human activity datasets for training robotics and physical AI models.

$30MSeed round · Oct 22, 2026
Enact Intelligence

Enact Intelligence develops robot intelligence that uses force and touch to improve physical manipulation.

$30MPre-seed · Oct 22, 2026

Related